TypeOnline Course
DateNov 1, 2015
Student Enrolled2
Price$550 / Rs. 27500
Buy NowBook Now

Admission Process

Admission Process

Upon receiving your filled up application form, our admin team will generate PROVISIONAL ADMISSION ID and send you the PROVISIONAL ADMISSION LETTER along with instruction to course fees payment options.

Course Application Form

Introduction

Features

Eligibility

Course Fees

Course Objective: The objective of this course is to impart knowledge and understanding of the Pharmaceutical Strategic Business Management from the 360 degree from the different areas of Pharmaceutical Management.

Key Learning Area for the course

  • Drug Development to Commercialization
  • Innovation Management in pharmaceutical industry
  • Pharma Marketing Strategic Planning
  • Generic Drug Strategic Planning
  • Production Planning and Strategic Management in pharmaceutical industry
  • Managing pharmaceutical SBU revenue model
  • Drug Registration overseas
  • International Marketing strategic planning in pharmaceutical
  • Licensing in pharmaceutical industry – In Licensing Vs. Out licensing
  • Pharmaceutical Business Audit
  • Human Resource strategic planning for pharmaceutical company
  • QA/QC Team – Differentiator of Today’s pharmaceutical manufacturing organization
  • Financial Planning and Management for pharma strategic management professionals
  • Accreditation Management and PR strategies for pharmaceutical firms
  • Web strategies for Pharmaceutical companies

1. Orientation to job related practical strategic business management related activities from different discipline of Pharmaceuticals.

2. Simulation to real life Strategic Management.

3. Access to Industry Databank – 300 Strategic Management examples etc.

4. Access to 1000’s of Pharmaceutical Case Studies

5. Attend Live Lectures of all different chapters / study content.

Minimum qualification Graduation in any discipline with more than 24 months of work experience in Pharmaceutical  domain. Work Experience is mentioned is mandatory for admission into this course.

Rs. 27500 (payment from India) / 550 USD (payment from outside India)

Course Flow

Section 1Introduction to Pharmaceutical Strategic Management
Lecture 1Introduction to R&D Process & drug discovery
Lecture 2Investigational New Drug Application
Lecture 3New Drug Application (NDA) 
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) 
Lecture 6Review on Drug Discovery and Development 
Lecture 7Strategic management – Strategic decision making – business level sub strategies
Lecture 8Expedited Drug Development Program
Lecture 9Practical Training on INDA, NDA, ANDA filing
Lecture 10505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 11Authorized Generics: Key Understanding
Lecture 12Exploratory IND Vs. Traditional IND
Lecture 13Patents Vs. exclusivity 
Lecture 14Strategic Learning from New Drug Development
Lecture 15Orphan Drug Designation 
Lecture 16Advance Strategic Learning on 505B2 Pathway
Section 2Clinical Research - Pharma R&D Strategic Orientation
Lecture 17Clinical Trial Terminologies
Lecture 18Clinical Trial Protocol Writing
Lecture 19Ethics in Clinical Research
Lecture 20Informed Consent 
Lecture 21Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !
Section 3Intellectual Property Management
Lecture 22Patent and Trademark Office - How they work?
Lecture 23Patent
Lecture 24Application For Patent
Lecture 25Trademark
Lecture 26Steps Know How & Key Points - Patent Application 
Lecture 27Fundamental Understanding of Patent, Trademark Licensing and related terminology
Section 4Pharma Marketing - Brand Management
Lecture 28Introduction to Pharma Marketing
Lecture 29Market Research in Pharma Business
Lecture 30Consumer buying behavior
Lecture 31Product Life cycle - Basic Understanding
Lecture 32STP - Strategic Positioning and Brand Differentiation
Lecture 33Pricing Strategies
Lecture 34Distribution and Logistics
Lecture 35Pharmaceutical Distribution
Lecture 36Promotion Management Process in a Pharmaceutical Company
Lecture 37Setting and Quantifying Promotional Objectives
Lecture 38Promotional Budget Setting : Tools and Techniques
Lecture 39Basics of Advertising : Introduction
Lecture 40Classifications of Advertising
Lecture 41The Advertising agency
Lecture 42Classification of Doctors
Lecture 43Moving Annual Total (MAT)
Lecture 44CAGR
Lecture 45Brand Potential
Section 5Pharma Brand Strategy Management
Lecture 46PRATICAL TRAINING SESSION : BRAND NAME,  BRAND LOGO, TRADEMARKING 
Lecture 47Purpose of Pharma Brand Logo
Lecture 48Component of brand logo
Lecture 49Brand Name and TM Registration Process
Lecture 50How to design excellent brand logo?
Lecture 51Case study in brand name finalization
Lecture 52Brand Name Simulation
Lecture 53Traditional Vs. Non-Traditional trademark
Lecture 54Global Protection of the Pharma Brand
Lecture 55Rebranding in Pharmaceuticals
Lecture 56Brand Logo Development: Real Life Simulation
Lecture 57Fundamental of Pharma Marketing Plan 
Lecture 58Basic Know-How: Marketing Campaign Development 
Lecture 59How to prepare a Pharma Brand Plan 
Lecture 60Decide about brand USP -What to promote 
Lecture 61How to prepare promotogram. Download sample Promotogram
Lecture 62Sample Allocation 
Lecture 63Importance of Visual Aid in Pharmaceutical Industry
Lecture 64BUYING SIGNAL
Lecture 65Indications for Drugs: Approved vs. Non-approved 
Lecture 66Case Study : Indication approval to extend the usage of the brands (molecule) 
Lecture 67Step By Step Visual Aid Designing
Lecture 68Guideline of Visual Aid Designin
Lecture 69Practical Sample to understand visual aid contents and effective placement of the texts
Lecture 70VISUAL AID PRINTING 
Lecture 71Detailing and e-detailing
Lecture 72Marketing Plan followed by Visual Aid Development
Lecture 73Visual Aid, Literature reference Sample
Lecture 74Creativity to develop brand essence
Lecture 75Increase the brand reach with advance segmentation
Lecture 76Concept of uniform branding for better brand acceptability
Lecture 77Concept of Brand Differentiation
Section 6Biopharmaceuticals and Biosimilar Development Process
Lecture 78Introduction : Biopharmaceuticals
Lecture 79Classification of Biopharmaceutical 
Lecture 80Introduction to Biosimilar
Lecture 81Chemical Drugs Vs. Biologic Drugs
Lecture 82Current Trends in Biopharmaceutical Market
Lecture 83Dynamics of Biopharmaceutical Market
Lecture 84Complexity of biopharma supply chain and operations
Lecture 85Biopharma - Market Segmentation
Lecture 86Blockbuster Biologic - Classifications,  Indications, Global Sales
Lecture 87Recombinant protein
Lecture 88Monoclonal Antibodies Vs. Polyclonal Antibodies
Lecture 89Monoclonal Antibodies
Lecture 90Synthetic Immunomodulators
Lecture 91Production of Monoclonal Antibodies
Lecture 92Cytokines
Lecture 93Interferon
Lecture 94Erythropoiesis-stimulating agent
Lecture 95Biological Licensing Application (BLA) 
Lecture 96Biosimilar Approval process
Lecture 97Difference : Drugs Vs. Biopharmaceutical Approval process
Lecture 98Pricing and cost effectiveness of biosimilars
Lecture 99Exclusivity Protections for Biopharmaceuticals
Lecture 100REMS Strategic Planning 
Lecture 101Review : 351(a) vs. 351(k) pathway
Section 7Stretgic Planning in Pharmaceuticals & Biopharmaceuticals
Lecture 102Strategies in different phases of Clinical Trial
Lecture 103Lifecycle Extension Strategies - Evergreening
Lecture 104Advance Study in Para IV filing
Lecture 105Evergreening - Patent Life Extension Strategies
Lecture 106Pay For Delay Strategy
Lecture 107Compulsory Licensing
Lecture 108In-Licensing Vs. Outlicensing
Lecture 109LOE Strategies for Innovator Brands with case study
Lecture 110Paediatric Exclusivity and Paediatric Study Plan Development
Lecture 111Drug Repurposing
Section 8Advance Portfolio Management
Lecture 112Advance understanding of the portfolio Management 
Lecture 113Co-promotion & Co-marketing strategy
Lecture 114Reverse co-promotion
Lecture 115New Indication Approval Process and Promotion
Lecture 116Publication Management for strategic positioning of the brands
Lecture 117Juxtapid Case Study
Lecture 118OTC Switch 
Lecture 119Rx to OTC switch - case study
Section 9Strategic Orientation in Pharma and Biopharma industry
Lecture 120Licensing Vs. Outlicensing in Pharma / Biopharma Industry
Lecture 121Licensing - Advance Strategic Learning
Lecture 122Terms / Duration of License
Lecture 123Are improvements licensed
Lecture 124Financial of Licensing Deals
Lecture 125Milestone Payment
Lecture 126How are royalties structured in a licensing deal?
Lecture 127What accounts, inspection and audit provisions are in a license?
Lecture 128How is patenting dealt with in a license?
Lecture 129What warranties are in a license?
Lecture 130What competition law issues are there in licensing?
Lecture 131Co-development and co-marketing agreements in Pharmaceutical Strategic Management
Lecture 132Due Diligence Activities in Pharmaceutical Licensing
Lecture 133Detailed in-depth strategic understanding on Technology Transfer
Lecture 134Overview of contractual agreements in Technology Transfer
Lecture 135Confidentiality agreements
Lecture 136Material Transfer Agreements
Lecture 137Deeds of assignment or assignment deeds
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,